(Q34918418)

5 August 2017

1 reference

title

Beta-herpesvirus challenges in the transplant recipient (English)

1 reference

5 August 2017

Per Ljungman

1

1 reference

PubMed ID

12353194

5 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of Infectious Diseases

5 August 2017

1 reference

5 August 2017

186 Suppl 1

1 reference

5 August 2017

S99-S109

1 reference

Cytomegalovirus disease and allograft loss after organ transplantation

5 August 2017

1 reference

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus

21 January 2018

1 reference

Human herpesvirus-6 and -7 in transplantation

21 January 2018

1 reference

Recent advances in the therapy and prevention of CMV infections

21 January 2018

1 reference

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

21 January 2018

1 reference

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

21 January 2018

1 reference

Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group

21 January 2018

1 reference

Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants

21 January 2018

1 reference

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

21 January 2018

1 reference

Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy

21 January 2018

1 reference

A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis S

21 January 2018

1 reference

Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).

21 January 2018

1 reference

Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients

21 January 2018

1 reference

Viral dynamics during active cytomegalovirus infection and pathology

21 January 2018

1 reference

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation

21 January 2018

1 reference

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

21 January 2018

1 reference

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation

21 January 2018

1 reference

New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients

21 January 2018

1 reference

High-Dose Oral Acyclovir Reduces the Incidence of Cytomegalovirus Infection in Liver Transplant Recipients

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

Valacyclovir prevention of cytomegalovirus reactivation after heart transplantation: a randomized trial

21 January 2018

1 reference

Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections

21 January 2018

1 reference

Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation

21 January 2018

1 reference

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

21 January 2018

1 reference

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

Genetic content of a 20.9 kb segment of human herpesvirus 6B strain Z29 spanning the homologs of human herpesvirus 6A genes U40-57 and containing the origin of DNA replication

21 January 2018

1 reference

The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution

21 January 2018

1 reference

Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo

21 January 2018

1 reference

Human herpesvirus-6 in transplantation: an emerging pathogen

21 January 2018

1 reference

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

21 January 2018

1 reference

Neuroinvasion and persistence of human herpesvirus 6 in children

21 January 2018

1 reference

Encephalitis caused by human herpesvirus-6 in transplant recipients: relevance of a novel neurotropic virus

21 January 2018

1 reference

Fever in liver transplant recipients: changing spectrum of etiologic agents.

21 January 2018

1 reference

Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients

21 January 2018

1 reference

Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity.

21 January 2018

1 reference

Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction

21 January 2018

1 reference

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study.

21 January 2018

1 reference

PROSPECTIVE STUDY OF HUMAN BETAHERPESVIRUSES AFTER RENAL TRANSPLANTATION

21 January 2018

1 reference

Human herpesvirus-6 infection after liver transplantation

21 January 2018

1 reference

"Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?

21 January 2018

1 reference

CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy

21 January 2018

1 reference

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

21 January 2018

1 reference

High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients

21 January 2018

1 reference

A multiplex PCR assay for the simultaneous detection of human herpesvirus 6 and human herpesvirus 7, with typing of HHV-6 by enzyme cleavage of PCR products

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/342962

1 reference

5 August 2017

1 reference

PubMed ID

12353194